Hepatitis C virus intrinsic molecular determinants may contribute to the development of cholestatic hepatitis after liver transplantation
- 1 January 2019
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 100 (1) , 63-68
Abstract
Cholestatic hepatitis C (CHC) is a severe form of hepatitis C virus (HCV) infection recurrence that leads to high graft loss rates early after liver transplantation (LT). To investigate the pathogenic mechanisms of CHC, we analysed HCV quasispecies in CHC patients compared to a control group (mild hepatitis C recurrence) by deep pyrosequencing. At the time of LT, NS5B quasispecies complexity was similar between the two groups but, after LT, it decreased more sharply in CHC patients than in the control group. Interestingly, the major variant before LT propagated efficiently and remained as the dominant sequence after LT in 62 % of CHC patients versus 11 % of controls (P=0.031). Sequence analysis of the complete non-structural region in a limited number of patients revealed a potential 12 aa signature specific to the CHC group. These data suggest that intrinsic molecular determinants in the circulating HCV quasispecies may provide a fitness advantage, contributing to the development of CHC.Keywords
This publication has 38 references indexed in Scilit:
- Early Acute Severe HCV Recurrence After Transplantation: From Universal Mortality to CureJournal of Clinical and Experimental Hepatology, 2017
- Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trialThe Lancet Infectious Diseases, 2016
- Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver TransplantationClinical Gastroenterology and Hepatology, 2015
- P0779 : Ledipasvir/sofosbuvir with ribavirin for the treatment of fibrosing cholestatic hepatitis C after liver transplantationJournal of Hepatology, 2015
- Progression of liver fibrosis in post-transplant hepatitis C: Mechanisms, assessment and treatmentJournal of Hepatology, 2013
- Viral Hepatitis in Liver TransplantationGastroenterology, 2012
- Post–liver transplant cholestatic hepatitis C: A systematic review of clinical and pathological findings and application of consensus criteriaLiver Transplantation, 2010
- The natural history of recurrent hepatitis C and what influences thisLiver Transplantation, 2008
- Early Histologic Changes in Fibrosing Cholestatic Hepatitis CLiver Transplantation, 2007
- Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis CLiver Transplantation, 2003